Specialties
Reports that name this provider
- Clinical Trial Access in Brazil
- National cancer institute; planned R$2.5 billion mega campus with 18 integrated units; new National Clinical Research Program (PPClin) with R$120 million secured for 2026
- Second Opinion Services in Brazil
- Public sector facility; reserved for Brazilian residents; not available to medical tourists; operates under severe capacity constraints